US 9259452
Deacetylase inhibitor therapy
granted A61KA61K31/19A61K33/00
Quick answer
US patent 9259452 (Deacetylase inhibitor therapy) held by THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES
- Grant date
- Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K31/19, A61K33/00, A61K33/06, A61K33/14